Search research articles
Contact Us
Filters
Showing results (91-100 of 128) with videos related to
Page
of 13
Sort By:
British Journal of Haematology
|
July 6, 2016
Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma
Dai Chihara, Jason R Westin, Roberto N Miranda, et al.
American Journal of Hematology
|
May 26, 2016
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration
Chan Y Cheah, Paul J Bröckelmann, Dai Chihara, et al.
Haematologica
|
April 7, 2018
A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
Paolo Strati, Dai Chihara, Yasuhiro Oki, et al.
Advances in Radiation Oncology
|
November 11, 2024
Ultra-Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung
Susan Y Wu, Penny Q Fang, Ahmed Fetooh, et al.
British Journal of Haematology
|
August 12, 2015
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma
Dai Chihara, Barbara Pro, Sanam Loghavi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2026
A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma
Ehsan Irajizad, Johannes F Fahrmann, Hiroyuki Katayama, et al.
Cancer
|
June 29, 2016
Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma
Dai Chihara, Jason R Westin, Yasuhiro Oki, et al.
Leukemia & Lymphoma
|
November 3, 2025
Occurrence and predictors of patient reported fertility discussions in non-Hodgkin lymphoma patients: utilizing the lymphoma epidemiology of outcomes (LEO) cohort study
Nadia Toumeh, Melissa Larson, Brianna Negaard, et al.
Blood Advances
|
June 15, 2025
A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma
Neha Akkad, Lei Feng, Jason R Westin, et al.
Cancer
|
June 1, 2016
Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes
Gevorg N Tamamyan, Hagop M Kantarjian, Jing Ning, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 128) with videos related to
Sort By:
Page
of 13
British Journal of Haematology
|
July 6, 2016
Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma
Dai Chihara, Jason R Westin, Roberto N Miranda, et al.
American Journal of Hematology
|
May 26, 2016
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration
Chan Y Cheah, Paul J Bröckelmann, Dai Chihara, et al.
Haematologica
|
April 7, 2018
A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
Paolo Strati, Dai Chihara, Yasuhiro Oki, et al.
Advances in Radiation Oncology
|
November 11, 2024
Ultra-Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung
Susan Y Wu, Penny Q Fang, Ahmed Fetooh, et al.
British Journal of Haematology
|
August 12, 2015
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma
Dai Chihara, Barbara Pro, Sanam Loghavi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2026
A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma
Ehsan Irajizad, Johannes F Fahrmann, Hiroyuki Katayama, et al.
Cancer
|
June 29, 2016
Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma
Dai Chihara, Jason R Westin, Yasuhiro Oki, et al.
Leukemia & Lymphoma
|
November 3, 2025
Occurrence and predictors of patient reported fertility discussions in non-Hodgkin lymphoma patients: utilizing the lymphoma epidemiology of outcomes (LEO) cohort study
Nadia Toumeh, Melissa Larson, Brianna Negaard, et al.
Blood Advances
|
June 15, 2025
A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma
Neha Akkad, Lei Feng, Jason R Westin, et al.
Cancer
|
June 1, 2016
Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes
Gevorg N Tamamyan, Hagop M Kantarjian, Jing Ning, et al.
Page
of 13